AIM ImmunoTech Inc.

Keeping a Close Watch on AIM

262
AIM is one of the stocks that have underwhelmed me in performance lately. However given current resistance wedges, I think as an entry point right now it would seem low to mid risk. I believe going in as a long hold, you can expect some positive retracement, and quite possibly a $3.15 price target by end of August. That being said, pursue at your own risk. As always, everything I say is on the basis of opinion.

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.